[Treatment of psychological failure in aging man].
D000368:Aged; D000375:Aging; D000605:Amino Alcohols / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000188:drug therapy; D004338:Drug Combinations; D005260:Female; D005853:Geriatrics; D006415:Hematoporphyrins / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009756:Nylidrin / Q000627:therapeutic use; D011343:Procaine / Q000627:therapeutic use; D011613:Psychotherapy; D013566:Sympathomimetics / Q000627:therapeutic use*; D014815:Vitamins / Q000627:therapeutic use
D000605:Amino Alcohols; D004338:Drug Combinations; D006415:Hematoporphyrins; D013566:Sympathomimetics; D014815:Vitamins; D011343:Procaine; D009756:Nylidrin
Zur Behandlung psychischer Fehlleistungen des alternden Menschen.